Renoux Christel, Coulombe Janie, Li Linxin, Ganesh Aravind, Silver Louise, Rothwell Peter M
From the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (C.R., J.C.); Departments of Neurology and Neurosurgery (C.R.) and Epidemiology and Biostatistics (C.R.), McGill University, Montréal, Québec, Canada; and Center for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, United Kingdom (C.R., L.L., A.G., L.S., P.M.R.).
Stroke. 2017 Oct;48(10):2731-2738. doi: 10.1161/STROKEAHA.117.018187. Epub 2017 Aug 10.
Several studies have reported unexplained worse outcomes after stroke in women but none included the full spectrum of symptomatic ischemic cerebrovascular events while adjusting for prior handicap.
Using a prospective population-based incident cohort of all transient ischemic attack/stroke (OXVASC [Oxford Vascular Study]) recruited between April 2002 and March 2014, we compared pre-morbid and post-event modified Rankin Scale score (mRS) in women and men and change in mRS score 1 month, 6 months, 1 year, and 5 years after stroke. Baseline stroke-related neurological impairment was measured with the National Institutes of Health Stroke Scale.
Among 2553 patients (50.6% women) with a first transient ischemic attack/ischemic stroke, women had a worse handicap 1 month after ischemic stroke (age-adjusted odds ratio for mRS score, 1.35; 95% confidence interval, 1.12-1.63). However, women also had a higher pre-morbid mRS score compared with men (age-adjusted odds ratio, 1.58; 95% confidence interval, 1.36-1.84). There was no difference in stroke severity when adjusting for age and pre-morbid mRS (odds ratio, 1.10; 95% confidence interval, 0.90-1.35) and no difference in the pre-/poststroke change in mRS at 1 month (age-adjusted odds ratio, 1.00; 95% confidence interval, 0.82-1.21), 6 months, 1 year, and 5 years. Women had a lower mortality rate, and there was no sex difference in risk of recurrent stroke.
We found no evidence of a worse outcome of stroke in women when adjusting for age and pre-morbid mRS. Failure to account for sex differences in pre-morbid handicap could explain contradictory findings in previous studies. Properties of the mRS may also contribute to these inconsistencies.
多项研究报告称,女性中风后的预后情况较差且原因不明,但均未涵盖所有有症状的缺血性脑血管事件,同时也未对既往残疾情况进行校正。
我们利用一个基于人群的前瞻性发病队列,该队列纳入了2002年4月至2014年3月期间招募的所有短暂性脑缺血发作/中风患者(牛津血管研究[OXVASC]),比较了女性和男性病前及事件后的改良Rankin量表评分(mRS),以及中风后1个月、6个月、1年和5年时mRS评分的变化。采用美国国立卫生研究院卒中量表评估基线时与中风相关的神经功能缺损情况。
在2553例首次发生短暂性脑缺血发作/缺血性中风的患者中(女性占50.6%),女性在缺血性中风后1个月时的残疾情况更严重(mRS评分的年龄校正比值比为1.35;95%置信区间为1.12 - 1.63)。然而,与男性相比,女性病前的mRS评分也更高(年龄校正比值比为1.58;95%置信区间为1.36 - 1.84)。在校正年龄和病前mRS后,中风严重程度无差异(比值比为1.10;95%置信区间为0.90 - 1.35),且在1个月(年龄校正比值比为1.00;95%置信区间为0.82 - 1.21)、6个月、1年和5年时,中风前后mRS评分的变化也无差异。女性的死亡率较低,且复发性中风的风险在性别上无差异。
在校正年龄和病前mRS后,我们未发现女性中风预后更差的证据。既往研究中相互矛盾的结果可能是由于未考虑病前残疾情况的性别差异所致。mRS的特性也可能导致了这些不一致性。